ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
Valiant Organics Ltd reported revenue from operations of ₹304.2 Cr (+93.4% YoY) and net profit of ₹17.3 Cr (+203.5% YoY) for Q2 FY27.
Valiant Organics schedules a board meeting on November 5, 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until November 7, 2026.
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.
Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.
Promoter Vicky Hemchand Gala purchased 3,500 shares of Valiant Organics via a market transaction. This increases the promoter's stake by 0.01%.
Promoter Vicky Hemchand Gala acquired 3,500 shares of Valiant Organics Ltd via a market purchase. This increases the promoter's holding from 0.92% to 0.93%.
Designated Person Siddharth Dinesh Shah HUF acquired 1,000 shares of Valiant Organics Ltd through a market purchase, valued at Rs. 3,27,350.00.
Valiant Organics Ltd filed a Regulation 7(2) PIT disclosure reporting equity trades executed by designated persons Siddharth Dinesh Shah HUF and Ishita Siddharth Shah.
Valiant Organics Limited issued a notice for its Annual General Meeting scheduled on September 29, 2026, to approve financial statements and related party transactions.
Valiant Organics has filed its Annual Report and Notice of the 21st Annual General Meeting for the financial year 2025-26.
Valiant Organics reported a strong Q1-FY27 with revenue reaching INR 2,315 Mn and EBITDA margins expanding to 17.97%, the highest in six quarters, driven by raw material savings and operating leverage.
Valiant Organics Limited announced the re-appointment of Mr. Sathiababu K. Kallada as Executive Director for a 36-month term effective May 24, 2027.
Valiant Organics has granted 18,000 Employee Stock Options to an eligible employee under its 2022 ESOP Scheme. The exercise price per option is Rs. 10.
Valiant Organics Ltd reported revenue from operations of ₹231.5 Cr (+13.3% YoY) and net profit of ₹29.3 Cr (+257.3% YoY) for Q1 FY27.
Valiant Organics Limited scheduled a board meeting on August 12, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
CRISIL Ratings reaffirmed the credit ratings of Valiant Organics Limited, revising the outlook to 'Stable'. The total bank loan facilities rated are Rs. 370 Crore.
CRISIL Ratings reaffirmed credit ratings for Valiant Organics Ltd's bank facilities and revised the long-term outlook to 'Stable'. The total rated facility is ₹370 Crore.
The company filed its quarterly shareholding pattern for June 2026. It also reported the allotment of 15,000 equity shares upon the exercise of employee stock options.
Valiant Organics reported a significant FY26 turnaround with Revenue of ₹7,388 Mn (+3% YoY) and PAT of ₹332 Mn, recovering from a loss. Performance was driven by structural cost optimization and improved realizations.
Valiant Organics issued a postal ballot for a ₹96.05 Crore related party transaction and subsidiary partnership cessation. Shareholders will vote on these material structural changes.
Valiant Organics Limited issued a postal ballot notice for member approval of two resolutions. The matters include ceasing as a partner in Dhanvallabh Ventures LLP.
Valiant Organics issued a corrigendum clarifying a material related party transaction with DVLLP involving a ₹6.34 Crore payment. The transaction includes transferring 1,86,07,531 shares.
Valiant Organics Limited will acquire 1,86,07,531 equity shares of Valiant Laboratories Limited off-market for ₹116.69 Crore. The acquisition facilitates internal restructuring within the promoter group.
Valiant Organics will exit its subsidiary Dhanvallabh Ventures LLP. Consideration involves receiving 1,86,07,531 shares of Valiant Laboratories Limited upon completion.
Valiant Organics is evaluating restructuring options to simplify its corporate structure and achieve strategic synergies. The board has granted in-principle approval for this strategic realignment.
Valiant Organics Ltd reported revenue from operations of ₹217.8 Cr (+6.9% YoY) and net profit of ₹15.7 Cr (+273.8% YoY) for Q4 FY26.
Valiant Organics reported standalone annual total income of ₹745.29 Crore and approved pharma business as a reportable segment. Auditors issued an unmodified opinion for FY26.
Valiant Organics Limited's board approved exploring internal restructuring options to achieve strategic synergies. The evaluation aims to unlock shareholder value through simplified holding structures.